cGAS produces a 2-5-linked cyclic dinucleotide second messenger that activates STING
It's an investigational drug currently in Phase 3 clinical trials Eli Lilly's TRIUMPH Phase 3 program includes multiple trials for obesity, type 2 diabetes, NASH, and cardiovascular outcomes Expected timeline: FDA submission in 2026, potential approval in 20272028 Phase 2 results showed 24.2% weight loss at 48 weeks, the highest ever recorded for a GLP-1 class medication How to access now: Clinical trial enrollment (free), compounding pharmacies (with important legal caveats), or research peptides (grey market) When approved, retatrutide will be the first triple-agonist obesity medication (GLP-1 + GIP + glucagon) Is Retatrutide FDA Approved
ABOUT UMBRELLA LABS Umbrella Labs is a U.S
subtilis biofilm studies, the master regulator that controls the expression of these genes, SinR, and its repressor SinI, 27 were upregulated in biofilm-associated cells
MIC B12 injections, also known as lipotropic injections, combine methionine, inositol, choline, and vitamin B12 to create a unique formula that may have an influence on metabolism and energy levels
